Basic info
Industry
research services
Sectors
Integrated Drug Discovery
Biotechnology
Contract Research Organization
Discovery Chemistry
Syngene
Oligonucleotides
Chemical Development
Putting Science to Work
Biologics Manufacturing
Pharmaceutical
Contract Manufacturing Organization
Drug Manufacturing
Drug Discovery
Biopharma Outsourcing
Research Services
Discovery Biology
Manufacturing
Drug Development
Biology and Biologics
Bioinformatics
Clinical Development Services
Pharma Biotech
Formulations Development
Date founded
1993
Funding rounds raised
Total raised
$145M
from 3 investors over 3 rounds
S
Syngene International Limited raised $145M on February 2, 2023
Investors: Caisse de dépôt et placement du Québec (CDPQ), Abu Dhabi Investment Authority (ADIA) and GIC